Cancer clones evolution in some forms of haemoblastosis


Cite item

Full Text

Abstract

The process of cancer clones evolution in haemoblastosis is going in two directions. The first direction comprises development of independent clones each of them accumulating specific injuries not find in other clones. The second direction consists in one initial clone becoming more complex by addition of new injuries. Both directions may be explained by high genetic unstability of the cells. Haematological cancer may have origin in normal stem cells and in normal precursor cells as it was shown for some forms of leucosis.

About the authors

S N Kolubaeva

S. M. Kirov Military Medical Academy. St. Petersburg

Санкт-Петербург, ул. Академика Лебедева, 6

A V Novitsky

S. M. Kirov Military Medical Academy. St. Petersburg

Санкт-Петербург, ул. Академика Лебедева, 6

N A Victorova

S. M. Kirov Military Medical Academy. St. Petersburg

Санкт-Петербург, ул. Академика Лебедева, 6

O P Krasnova

S. M. Kirov Military Medical Academy. St. Petersburg

Санкт-Петербург, ул. Академика Лебедева, 6

A M Ivanov

S. M. Kirov Military Medical Academy. St. Petersburg

Санкт-Петербург, ул. Академика Лебедева, 6

References

  1. Kakarala М., Wicha M.S. Cancer stem cells: Implications for cancer treatment and prevention // Cancer J. 2007. Vol. 13. № 5. P. 271-274.
  2. Holden C. Stem cells. Reprogramming, take two // Sience. 2007. № 316. P. 1404.
  3. Dontn G., Liu S., Wicha M.S. Stem cells in mammary development and carcinogenesis. Implications for prevention and treatment // Stem Cell Rev. 2005. Vol. 1. P 207-214.
  4. Wodarz A., Gonsales C. Connecting cancer to asym- metryc division of stem cells // Cell. 2006. Vol. 124. №24. P. 1121-1123.
  5. Ting X., Li L. Stem cells and their niche: an inseparable relationship // Development. 2007. № 134. P 2001- 2006.
  6. Li L., Xie T. Stem cells niche: structure and function // Ann. Rev. Cell. Dev. Biol. 2005. № 21. P 605-621.
  7. Burkert J., Wright N., Alison M. Stem cells and cancer: an intimate relationship // J. Pathol. 2006. № 209. P 287-297.
  8. Wang J.C., Dick J.E. Cancer stem cells: lessons from leukemia И Trends Cell Biol. 2005. № 15. P. 494- 501.
  9. Delerba P Cho R.W., Clarke M.F. Cancer stem cells: models and concepts // Ann. Rev. Med. 2007. № 58. P. 267-284.
  10. Polyak R., Hahn W.C. Roots and stems: Stem cells in cancer//Nat. Med. 2006. № 12. P. 296-300.
  11. Богданов A.H., Саржевский В.О., Колюбаева С.Н. и др. Случай острого лимфобластного лейкоза с транслокацией t(9;22) и несколькими дополнительными перестройками // Гематол. и трансфузиол. 2008. Т. 53. № 3. С. 35-38.
  12. An International System for Human Cytogenetic Nomenclature // Recommendations of International Standing Commitee on Human Cytogenetic Nomenclature / Eds. L. Shaffer, N. Tommerup. Basel: S. Karger, 2005.
  13. Lambrechts A.C., Hupkes P.E., Dorssers L.C., van’t Veer M.B. Translocation (14;18)-positive cells are present in the circulation of the majority of patients with localized (stage I and II) follicular non- Hodgkin’s lymphoma // Blood. 1993. Vol. 82. № 8. P.2510-2516.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2011 Kolubaeva S.N., Novitsky A.V., Victorova N.A., Krasnova O.P., Ivanov A.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).